Registro:

Referencias:

• Abriouel, H., Franz, C., Ben Omar, N., Galvez, A., Diversity and applications of Bacillus bacteriocins (2011) FEMS Microbiol Rev, 35, pp. 201-232
• Albiol Matanic, V., Castilla, V., Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus (2004) Int J Antimicrob Agents, 23, pp. 382-389
• Andersen, J., Osbakk, S., Vorland, L., Traavik, T., Gutteberg, T., Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts (2001) Antiviral Res, 51, pp. 141-149
• Azwa, A., Barton, S., Aspects of herpes simplex virus: a clinical review (2009) J Fam Plann Reprod Health Care, 35, pp. 237-242
• Babasaki, K., Takao, T., Shimonishi, Y., Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis (1985) J Biochem, 98, pp. 585-603
• Baghian, A., Kousouglas, K., Role of the Na+ K+ pump in herpes simplex type 1-induced cell fusion: melittin causes specific reversion of syncytial mutants with the syn 1 mutation to syn+ (wild-type) phenotype (1993) Virology, 196, pp. 548-556
• Balla, E., Dicks, L., Du Toit, M., Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecium BFE 1071 (2000) Appl Environ Microbiol, 66, pp. 1298-1304
• Belaid, A., Aouni, M., Khelifa, R., Trabelsi, A., Jemmali, M., Hani, K., In vitro antiviral activity of dermaseptins against herpes simplex virus type 1 (2002) J Med Virol, 66, pp. 229-234
• Berger, J., Houff, S., Neurological complications of herpes simplex virus type 2 infection (2008) Arch Neurol, 65, pp. 596-600
• Celum, C., Wald, A., Lingappa, J., Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 (2010) N Engl J Med, 362, pp. 427-439
• Chilukuri, S., Rosen, T., Management of acyclovir-resistant herpes simplex virus (2003) Dermatol Clin, 21, pp. 311-320
• Choong, K., Walker, N., Apel, A., Whitby, M., Aciclovir-resistant herpes keratitis (2010) Clin Experiment Ophthalmol, 38, pp. 309-313
• Cintas, L., Rodriguez, J., Fernandez, M., Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum (1995) Appl Environ Microbiol, 61, pp. 2643-2648
• Daher, K., Selsted, M., Lehrer, R., Direct inactivation of viruses by human granulocyte defensins (1986) J Virol, 60, pp. 1068-1074
• Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival (1986) J Inmunol Methods, 89, pp. 271-277
• Duan, B., Yuan, X., Zhu, Y., A nanofibrous composite membrane of PLGA-chitosan/PVA prepared by electrospinning (2006) Eur Polymer J, 42, pp. 2013-2022
• Efstathiou, S., Preston, C., Towards an understanding of the molecular basis of herpes simplex virus latency (2005) Virus Res, 111, pp. 108-119
• Fatahzadeh, M., Schwartz, R., Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management (2007) J Am Acad Dermatol, 57, pp. 737-763
• Field, H., Herpes simplex virus antiviral drug resistance-current trends and future prospects (2001) J Clin Virol, 21, pp. 261-269
• Frasch, H., Dotson, G., Barbero, A., In vitro human epidermal penetration of 1-bromopropane (2011) J Toxicol Environ Health A, 74, pp. 1249-1260
• Gupta, R., Warren, T., Wald, A., Genital herpes (2007) Lancet, 370, pp. 2127-2137
• Håvard, J., Therapeutic approaches using host defense peptides to tackle herpes virus infections (2009) Viruses, 1, pp. 939-964
• Heunis, T., Botes, M., Dicks, L., Encapsulation of Lactobacillus plantarum 423 and its bacteriocin in nanofibers (2010) Probiotics Antimicrob Prot, 2, pp. 46-51
• Heunis, T., Bshena, O., Klumperman, B., Release of bacteriocins from nanofibers prepared with combinations of poly(D, L-lactide) (PDLLA) and poly(ethylene oxide) (PEO) (2011) Int J Mol Sci, 12, pp. 2158-2173
• Heunis, T., Dicks, L., Nanofibers offer alternative ways to the treatment of skin infections (2010) J Biomed Biotechnol, , pii 510682
• Hill, C., McKinney, E., Lowndes, C., Epidemiology of herpes simplex virus types 2 and 1 amongst men who have sex with men attending sexual health clinics in England and Wales: implications for HIV prevention and Management (2009) Euro Surveill, 14. , article 19418
• Hook, E., Cannon, R., Nahmias, A., Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection (1992) J Infect Dis, 165, pp. 251-255
• Jenssen, H., Hamill, P., Hancock, R., Peptide antimicrobial agents (2006) Clin Microbiol Rev, 19, pp. 491-511
• Johnston, C., Saracino, M., Kuntz, S., Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials (2012) Lancet, 379, pp. 641-647
• Lehrer, R., Daher, K., Ganz, T., Selsted, M., Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes (1985) J Virol, 54, pp. 467-472
• Looker, K., Garnett, G., Schmid, G., An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection (2008) Bull World Health Organ, 86, pp. 805-812
• Marx, R., Stein, T., Entian, K., Structure of the Bacillus subtillis peptide antibiotic subtilosin A determined by 1H NMR and matrix assisted laser desorption/ionization time-of-flight mass spectrometry (2001) J Protein Chem, 20, pp. 501-506
• Morfin, F., Thouvenot, D., Herpes simplex virus resistance to antiviral drugs (2003) J Clin Virol, 26, pp. 29-37
• Piret, J., Boivin, G., Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management (2011) Antimicrob Agents Chemother, 55, pp. 459-472
• Pongtharangkul, T., Demirci, A., Evaluation of agar diffusion bioassay for nisin quantification (2004) Appl Microbiol Biotechnol, 65, pp. 268-272
• Schulte, E., Sauerbrei, A., Hoffmann, D., Zimmer, C., Hemmer, B., Mühlau, M., Acyclovir resistance in herpes simplex encephalitis (2010) Ann Neurol, 67, pp. 830-833
• Serkedjieva, J., Danova, S., Ivanova, I., Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii (2000) Appl Biochem Biotechnol, 88, pp. 285-295
• Shin, J., Cai, G., Weinberg, A., Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates (2001) J Clin Microbiol, 39, pp. 913-917
• Shin, Y., Hohman, M., Brenner, M., Electrospinning: a whipping fluid jet generates submicron polymer fibers (2001) Appl Phys Lett, 78, pp. 1149-1151
• Steiner, I., Kennedy, P., Pachner, A., The neurotropic herpes viruses: herpes simplex and varicella-zoster (2007) Lancet Neurol, 6, pp. 1015-1028
• Sutyak, K., Anderson, R., Dover, S., Spermicidal activity of the safe natural antimicrobial peptide subtilosin (2008) Infect Dis Obstet Gynecol, 2008, p. 540758
• Sutyak, K., Wirawan, R., Aroutcheva, A., Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens (2008) J Appl Microbiol, 104, pp. 1067-1074
• Talarico, L., Castilla, V., Rámirez, J., Synergistic in vitro interactions between (22S,23S)-3β-bromo-5α22,23-trihydroxystigmastan-6-one and foscarnet against herpes simples virus type 1 (2006) Chemotherapy, 52, pp. 38-42
• Tamamura, H., Otaka, A., Murakami, T., Interaction of an anti-HIV peptide, T22, with gp120 and CD4 (1996) Biochem Biophys Res Commun, 219, pp. 555-559
• Thennarasu, S., Lee, D., Poon, A., Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A (2005) Chem Phys Lipids, 137, pp. 38-51
• Todorov, S., Wachsman, M., Knoetze, H., An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4 V isolated from soybeans (2005) Int J Antimicrob Agents, 25, pp. 508-513
• van Velzen, M., van Loenen, F., Meesters, R., Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals (2012) J Infect Dis, 205, pp. 1539-1543
• Wachinger, M., Kleinschmidt, A., Winder, D., Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression (1998) J Gen Virol, 79, pp. 731-740
• Wachsman, M., Castilla, V., de Ruiz Holgado, A., Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro (2003) Antivir Res, 58, pp. 17-24
• Wachsman, M., Farías, M., Takeda, E., Antiviral activity of enterocin CRL35 against herpesviruses (1999) Int J Antimicrob Agents, 12, pp. 293-299
• Wachsman, M., López, E., Ramírez, J., Antiviral effect of brassinosteroids against herpes virus and arenaviruses (2000) Antiviral Chem Chemother, 11, pp. 71-77
• Whitley, R., Roizman, B., Herpes simplex virus infections (2001) The Lancet, 357, pp. 1513-1518
• Yarin, A., Koombhongse, S., Reneker, D., Taylor cone and jetting from liquid droplets in electrospinning of nanofibers (2001) J Appl Phys, 90, pp. 4836-4846
• Yasin, B., Pang, M., Turner, J., Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides (2000) Eur J Clin Microbiol Dis, 19, pp. 187-194

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------